How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

111 results for

Hemicrania Continua

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Chronic Paroxysmal Hemicrania (Follow-up)

in distinguishing hemicrania continua (HC) and supraorbital nerve neuralgia (in which nerve block is markedly effective). Reliable evidence for the efficacy of chiropractic manipulation, acupuncture, or surgical management in the treatment of CPH does not exist. Consultations Consult with an ophthalmologist to evaluate ocular pathology such as glaucoma or orbital pseudotumor. References Sjaastad O, Dale I. Evidence for a new (?), treatable headache entity. Headache . 1974 Jul. 14(2):105-8. . Sjaastad O, Dale I (...) . 1993 Jul. 8(3):235-6. . Tarantino S, Vollono C, Capuano A, Vigevano F, Valeriani M. Chronic paroxysmal hemicrania in paediatric age: report of two cases. J Headache Pain . 2011 Apr. 12(2):263-7. . . Müller KI, Bekkelund SI. Hemicrania continua changed to chronic paroxysmal hemicrania after treatment with cyclooxygenase-2 inhibitor. Headache . 2011 Feb. 51(2):300-5. . Sjaastad O, Vincent M. Indomethacin responsive headache syndromes: chronic paroxysmal hemicrania and Hemicrania continua. How

2014 eMedicine.com

22. Hemicrania continua

Hemicrania continua Hemicrania continua - Wikipedia Hemicrania continua From Wikipedia, the free encyclopedia Hemicrania continua Hemicrania continua ( HC ) is a persistent that responds to . It is usually unremitting, but rare cases of remission have been documented. Hemicrania continua is considered a , meaning that it is not caused by another condition. Contents Symptoms [ ] In addition to persistent daily headache of HC, which is usually mild to moderate (and frequently severe), HC can (...) present other symptoms. These additional symptoms of HC can be divided into three main categories: Autonomic symptoms: conjunctival injection tearing rhinorrhea nasal stuffiness eyelid edema forehead sweating Stabbing headaches: Short, "jabbing" headaches superimposed over the persistent daily headache. Usually lasting less than one minute. Migrainous features: throbbing pain nausea and/or vomiting Cause [ ] The cause of hemicrania continua is unknown. Diagnosis [ ] The following diagnostic criteria

Full Text available with Trip Pro

2012 Wikipedia

23. Coexisting Trigeminal Autonomic Cephalalgias and Hemicrania Continua. (PubMed)

Coexisting Trigeminal Autonomic Cephalalgias and Hemicrania Continua. The trigeminal autonomic cephalalgias (TACs) and hemicrania continua (HC) share many clinical characteristics including unilateral pain and ipsilateral autonomic features. We report a patient with a history of migraine without aura who developed cluster headache and HC simultaneously. The distinctive clinical features and differential response profiles to various treatments indicates that they are distinct disorders. We

2010 Headache

24. Diagnostic delay and suboptimal management in a referral population with hemicrania continua. (PubMed)

Diagnostic delay and suboptimal management in a referral population with hemicrania continua. To investigate a clinical population of patients with hemicrania continua (HC), looking at the diagnostic problems they have encountered and their use of healthcare resources and at issues relating to the effectiveness of treatments.We directly interviewed 25 patients fulfilling the International Classification of Headache Disorders, 2nd edition diagnostic criteria for HC selected among 1612 subjects (...) (24%) were the most commonly used. Patients rated 73.7% of medications as ineffective, 22.5% (all NSAIDs) as partially effective, and 3.7% (rofecoxib and nimesulide) as effective.Hemicrania continua may be misdiagnosed and mistreated even by neurologists. There is a need for greater awareness and understanding of this condition.

2009 Headache

25. Headache

in association with ipsilateral cranial autonomic signs and symptoms. Cluster headache is the only relatively common member of this headache disorder family. The others are rare and are characterized by short attacks: paroxysmal hemicrania, hemicrania continua, hypnic headaches, and short, unilateral neuralgiform headache attacks with unilateral conjunctival injection and tearing (SUNCT). SUNCT can occur without the unilateral conjunctival injection and tearing. All of these are diagnosed clinically (...) Appropriateness Criteria ® 13 Headache Paroxysmal hemicranias are more frequent, and individual attacks are shorter in duration when compared with cluster headache. MRI of the brain with and without contrast should be performed in all patients with paroxysmal hemicranias. Trigeminal neuralgia is diagnosed by history, clinical evaluation, and the presence of paroxysmal and shock-like pain with a trigger zone in the distribution of the fifth cranial nerve. For trigeminal neuralgia refractory to medical therapy

2019 American College of Radiology

26. Facial presentations of migraine, TACs, and other paroxysmal facial pain syndromes. (PubMed)

with migraine, 2.3% (44 of 1,935) reported a facial involvement, most commonly in V2. Of these, 18 patients (40.9%) experienced the pain predominantly in the face. In patients with cluster headache, 14.8% (42 of 283) reported a facial involvement, of which 31.0% perceived the pain predominantly in the face. A facial involvement was seen in 45.0% of patients with paroxysmal hemicrania (9 of 20), 21.4% of patients with hemicrania continua (9 of 42), and 20.0% of patients with short-lasting unilateral

2019 Neurology

27. Guideline for primary care management of headache in adults

Guidelines Network guideline 29 and expert opinion of the Guideline Development Group. Section 5: cluster headache Cluster headache is managed with a number of pharmacologic therapies. These can be initiated and monitored in primary care, but early specialist referral is recommended because this headache type is uncommon, disabling, and challenging to manage. Recommended medications are outlined in . Section 6: other headache disorders This section of the guideline focuses on hemicrania continua

2015 Institute of Health Economics

28. Overview of Trigeminal Autonomic Cephalalgias: Nosologic Evolution, Diagnosis, and Management (PubMed)

Overview of Trigeminal Autonomic Cephalalgias: Nosologic Evolution, Diagnosis, and Management The term trigeminal autonomic cephalalgias (TACs) encompasses four primary headache disorders - cluster headache, paroxysmal hemicrania (PH), hemicrania continua (HC), short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)/short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA). All of these except HC

Full Text available with Trip Pro

2018 Annals of Indian Academy of Neurology

29. Classification of Trigeminal Autonomic Cephalalgia: What has Changed in International Classification of Headache Disorders-3 Beta? (PubMed)

, eyelid edema, and ptosis. In the current International Classification of Headache Disorders (ICHD-3 beta),[2] the TAC group includes cluster headache (CH), paroxysmal hemicrania (PH), short-lasting unilateral neuralgiform headache attacks (SUNHAs) and their 2 subforms - SUNHAs with conjunctival injection and tearing (SUNCT), SUNHAs with cranial autonomic symptoms (SUNA). Hemicrania Continua (HC) is also now included in the TAC group. Although the entities included under TACs seem broadly similar

Full Text available with Trip Pro

2018 Annals of Indian Academy of Neurology

30. Functional Neuroimaging in Trigeminal Autonomic Cephalalgias (PubMed)

Functional Neuroimaging in Trigeminal Autonomic Cephalalgias Functional neuroimaging was able to identify key structures for the pathophysiology of trigeminal autonomic cephalalgias (TACs) including cluster headache, paroxysmal hemicrania, and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing or cranial autonomic features and hemicrania continua. The posterior hypothalamus was the structure most consistently depicted with functional imaging

Full Text available with Trip Pro

2018 Annals of Indian Academy of Neurology

31. Pain Biomarker Study

system. This study translates rodent data into humans in a non-invasive way to confirm the mechanism of this very effective treatment. Use of ice water to trigger headaches - brain freeze causes a very short-lived but intense headache that may cause similar biomarker release as other headache disorders. This may be a useful human model for other headache disorders. Condition or disease Intervention/treatment Phase Migraine Cluster Headache Trigeminal Autonomic Cephalgia Hemicrania Continua Paroxysmal (...) -lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), and hemicrania continua; b. Diagnosed by a pain medicine physician with lumbar radiculopathy (possibly including neuropathic features, nerve impingement on MRI, or electromyography (EMG) report suggestive of lumbar radiculopathy); or c. Healthy control subject with no history of debilitating headaches or debilitating back pain / radiculopathy pain, and no headaches or back pain within the previous 3 months. Able

2018 Clinical Trials

32. A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

or if they meet hepatic monitoring criteria Participants who, in the investigator's judgment, are actively suicidal and therefore deemed to be at significant risk for suicide History, within past 12 months, of chronic migraine or other forms of primary or secondary chronic headache disorder (eg, hemicranias continua, medication overuse headache where headache frequency is ≥15 headache days per month) Use of more than 3 doses per month of either opioids or barbiturates Initiation of or a change in concomitant

2018 Clinical Trials

33. Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias (PubMed)

Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias Trigeminal autonomic cephalalgia (TAC) encompasses 4 unique primary headache types: cluster headache, paroxysmal hemicrania, hemicrania continua, and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing and short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms. They are grouped on the basis of their shared clinical features of unilateral

Full Text available with Trip Pro

2018 Neurotherapeutics

34. Primary Care Management of Headache in Adults

Practice Guideline Page 2 of 76 Recommendations Section 1: Headache Diagnosis and Investigation Scope of Guideline Disease/Conditions(s) Targeted: ? Primary headache disorders: o Migraine o Tension-type headache o Cluster headache o Hemicranias continua o New daily persistent headache ? Secondary headaches: o Medication-overuse headache o Cervicogenic headache o Headache secondary to temporomandibular disorders Category: ? Prevention ? Diagnosis ? Evaluation ? Management ? Treatment Intended Users (...) | September 2016 Clinical Practice Guideline Page 6 of 76 Recommendations Section 1: Headache Diagnosis and Investigation cont’d Recommendation Evidence Source Legend on Page 43) A. Diagnose hemicranias continua if their headache: 1) is strictly unilateral; 2) is always on the same side of the head (ptosis and/or miosis may be present on examination); and 3) responds dramatically to indomethacin. Refer to Section 6: Other Headache Disorders: neurologist referral is recommended. EO (GDG) B. Diagnose new

2012 Toward Optimized Practice

35. Cluster headache and other TACs: Pathophysiology and neurostimulation options. (PubMed)

in some cases of other TACs, including hemicrania continua (HC) and short-lasting unilateral headache attacks (SUNHA).DBS has good results, but it is a more invasive technique and can generate serious adverse events. ONS has good results, but frequent and not serious adverse events. SPG stimulation (SPGS) is also efficacious in the acute and prophylactic treatment of refractory cluster headache. At this moment, ONS and SPG stimulation techniques are recommended as first line therapy in refractory

2017 Headache

36. Orofacial pain and headaches associated with exfoliation glaucoma. (PubMed)

, inflammation of the eyelids, and eyelid edema. Magnetic resonance imaging showed no evidence of intracranial or extracranial pathology. Hemicrania continua was considered as a possible diagnosis. Indomethacin was prescribed but did not affect her headaches. She then went to an ophthalmologist to rule out secondary headaches. Intraocular pressure was 13 millimeters of mercury in the right eye and 67 mm Hg in the left eye. The ophthalmologist made a diagnosis of exfoliation glaucoma, and the patient

2017 Journal of the American Dental Association

37. Tics in TACs: A Step into an Avalanche? Systematic Literature Review and Conclusions. (PubMed)

Tics in TACs: A Step into an Avalanche? Systematic Literature Review and Conclusions. Trigeminal autonomic cephalalgias (TACs) comprise cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks, and hemicrania continua. In some cases, trigeminal neuralgia (TN, "tic douloureux") or TN-like pain may co-occur with TACs.This article will review the co-occurrence and overlap of TACs and tics in order to contribute to a better understanding of the issue

2017 Headache

38. BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine

with brainstem aura, Migrainous infarction, Chronic tension-type headache, Hypnic headache, Hemicrania continua, New daily-persistent headache and Recurrent painful ophthalmoplegic neuropathy Participants with a confirmed history of medication overuse headache Participants with a diagnosis of retinal migraine, persistent aura without infarction or migraine-triggered seizure Headache attributable to another disorder (eg, cervical dystonia, craniotomy, head/neck trauma) Use of any headache prophylactic

2017 Clinical Trials

39. Benign Raeder syndrome evolving into indomethacin-responsive hemicranial headache. (PubMed)

Benign Raeder syndrome evolving into indomethacin-responsive hemicranial headache. Benign Raeder syndrome is characterized by a self-limiting unilateral continuous headache associated with ipsilateral ptosis, miosis, and frequently, facial hypohydrosis. Hemicrania continua is a chronic, strictly unilateral continuous headache associated with ipsilateral cranial autonomic symptoms. We report a 50-year-old man who presented with benign Raeder syndrome, which evolved into an indomethacin (...) -responsive hemicranial headache that resembled hemicrania continua.

2017 Headache

40. Prazosin for Post-Concussive Headaches

and/or tension-type HA disorder (for example hemicrania continua; cluster) that accounts for the majority of current symptoms. HAs of any kind of moderate or severe intensity on an average of more than 4 days per month preceding the concussive trauma Acute or serious medical illness or unstable chronic medical illness (e.g., unstable angina, myocardial infarction within 6 months, congestive heart failure, clinically significant or concerning cardiac arrhythmias; preexisting hypotension [systolic blood

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>